insights_auto
Why is IMC down ၈.၁၁%?
Dive Deeperchevron_right
IMC:ASX
Immuron Ltd
၀.၀၃၄ A$
arrow_downward
-၈.၁၁%(-၀.၀၀၃၀) 1D
နို ၁၉, GMT+၁၁ ၁၃:၅၂:၀၁ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMC...
Open
၀.၀၃ A$
High
၀.၀၃ A$
Low
၀.၀၃ A$
Mkt. cap
၁.၀၂ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၁.၈၁ သိန်း
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
Open
၀.၀၃ A$
High
၀.၀၃ A$
Low
၀.၀၃ A$
Mkt. cap
၁.၀၂ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၁.၈၁ သိန်း
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
News stories
From web sources and news partners
BeInCrypto
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
FXStreet
·
ပြီးခဲ့သည့် ၅ နာရီ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BigGo Finance
·
ပြီးခဲ့သည့် ၈ နာရီ
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees၈
Founded၁၉၉၄
HeadquartersBlackburn North, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
SectorHealth Care
Industry-
Websiteimmuron.com.au